Every round on record, with the sources behind each and the investors on them.
No description yet.
pharosyn.aiLondon, UKAIFounded 202511-50 people
5 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source states London as the base and identifies Pharosyn as a UK startup; no round stage, financing total, or valuation is stated.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $2.9M €2.5 million | 2026-09-02 | Moonfire | No recent discussion |
5 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 5 sources
The source states London as the base and identifies Pharosyn as a UK startup; no round stage, financing total, or valuation is stated. | ||||
Pharosyn builds custom AI infrastructure and competitive-intelligence monitoring for pharmaceutical commercial and portfolio-strategy teams.
Pharosyn targets a pharma workflow where its pages say traditional monitoring can take four hours; its AI cuts report delivery to about 15 minutes (a 94% reduction) and is already used by a top-10 biopharma and several mid-sized firms. The $3M seed led by Moonfire matters because it funds a team of eleven to push traceable, custom AI infrastructure deeper into commercial strategy, portfolio strategy, business development and licensing, market research, and forecasting—the company's bet that proprietary embedded AI can improve high-stakes resource allocation.
Checked against 8 sources on Oct 3